• About us
    • Successful cases
    • R+D
    • Clients
    • News
  • Particle
    technologies
  • Particle characterization
    • Services
      • Development and validation of PSD methods
      • Determination of accuracy of PSD methods
      • Particle morphological characterization
      • Solid state and crystallographic studies
      • Nano-Characterization
      • Analytical Development
    • Analysis
      • Granulometry - PSD
        • Laser Diffraction
        • Automated Optical Microscopy
      • Particle Morphology
        • Automated Optical Microscopy
        • Electron Microscopy
      • Nanoparticle Analysis
        • Dynamic Light Scattering
        • CRYO-TEM
      • Chemical Composition
        • HPLC (High-Performance Liquid Chromatography)
        • Image Analysis from Optical and Electron Microscopy
    • Quality
    • Case Studies
      • Analytical support into raw materials supplier qualification
      • Analytical investigation on OOS samples
      • Analytical investigation to support IP and regulatory procedures
      • Characterisation of nanostructures and nanoformulations
      • Comparison between development/test samples and Reference Drug Product/RLD samples
      • Image analysis studies from optical and electron microscopy
  • Contact us
Back to the gallery

News

Our paper has been selected for the cover image of the June 2021 issue of Advanced Therapeutics!
21 June 2021

Our paper has been selected for the cover image of the June 2021 issue of Advanced Therapeutics!

In the paper we report a soft, reliable, and scalable method based on compressed CO2 for obtaining nanoconjugates of recombinant human epidermal growth factors and nanovesicles. These nanoconjugates exhibit appropriate physicochemical properties together with an antimicrobial activity preventing infections that promote complete closure of complex wounds. Therefore, such nanoconjugates are a potential nanomedicine for the topical treatment of complex wounds, particularly diabetic foot ulcers.

 

https://onlinelibrary.wiley.com/toc/23663987/2021/4/6

 

The article has been authored by researchers from Nanomol Technologies SL, Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), Center for Genetic Engineering and Biotechnology (CIGB), Aarhus University and Leitat Technological Center. https://doi.org/10.1002/adtp.202000260

Related
news

Translation of DELOS nanovesicles formulations into new pharmaceutical candidates by Lídia Ballell 22 July 2022

Translation of DELOS nanovesicles formulations into new pharmaceutical candidates by Lídia Ballell

Nanomol Technologies will participate in the 11th annual PODD 22 October 2021

Nanomol Technologies will participate in the 11th annual PODD

Nanomol, one of the 10 companies selected for the BIOMED ScaleUP program 16 May 2022

Nanomol, one of the 10 companies selected for the BIOMED ScaleUP program

come and visit us

NANOMOL TECHNOLOGIES, S.L.
Mòdul de Recerca B
UAB CAMPUS

08193 Bellaterra
Cerdanyola del Vallès
Barcelona
Spain

get in touch

T +34 935 868 963
INFO@NANOMOL-TECH.COM

follow us

Twitter Linkedin

terms of use

Privacy policy Legality Cookies

Copyright © 2025

Nanomol Technologies S.L.

Site by Suki